We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Proton Therapy Effective for Prostate Cancer Treatment

By MedImaging International staff writers
Posted on 16 Jan 2012
Print article
Proton therapy, a type of external beam radiation therapy (EBRT), has been shown to be a safe and effective treatment for prostate cancer, according to two new studies.

The studies were published in the January 2012 issue of the International Journal of Radiation Oncology.Biology.Physics, the American Society for Radiation Oncology’s (ASTRO) official scientific journal. In the first study, researchers from the University of Florida (Jacksonville, USA) prospectively evaluated 211 men with low-, intermediate-, and high-risk prostate cancer.

After a two-year follow-up, the researchers, led by Nancy Mendenhall, MD, of the University of Florida Proton Therapy Institute, reported that the treatment was effective and that the gastrointestinal and genitourinary side effects were typically negligible. “This study is important because it will help set normal tissue guidelines in future trials,” Dr. Mendenhall, said.

In the second study, researchers from Massachusetts General Hospital (Boston, MA, USA), Loma Linda University Medical Center (Loma Linda, CA, USA) and the Radiation Therapy Oncology Group (Philadelphia, PA, USA) conducted a case-matched analysis comparing high-dose external beam radiation therapy using a combination of photons (X-rays) and protons with brachytherapy.

Over three years, 196 patients received the external beam treatments. Their data were compared to 203 men of similar stages who received brachytherapy over the same time period. The investigators then compared the biochemical failure rates (a statistical measure of whether the cancer relapses) and determined that men who received the proton/photon therapy had the same rate of recurrence as the men who received brachytherapy.

“For men with prostate cancer, brachytherapy and external beam radiation therapy using photons and protons are both highly effective treatments with similar relapse rates,” stated J. Coen, MD, a radiation oncologist at Massachusetts General Hospital. “Based on these data, it is our belief that men with prostate cancer can reasonably choose either treatment for localized prostate cancer based on their own concerns about quality of life without fearing they are compromising their chance for a cure.”

Related Links:

University of Florida
Massachusetts General Hospital
Linda University Medical Center



Digital Radiographic System
OMNERA 300M
New
Leg Wraps
Leg Wraps
New
Biopsy Software
Affirm® Contrast
X-ray Diagnostic System
FDX Visionary-A

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.